Paul Friedman

Paul Friedman

Chairman at PRELUDE THERAPEUTICS INCORPORATED

Net worth: 255 M $ as of 31/03/2024

81 year
Health Technology
Consumer Services
Commercial Services

Paul Friedman active positions

CompaniesPositionStartEnd
MADRIGAL PHARMACEUTICALS, INC. Director/Board Member 15/06/2023 -
Chief Executive Officer 22/07/2016 11/09/2023
Chairman 22/07/2016 15/06/2023
President 22/07/2016 11/09/2023
PRELUDE THERAPEUTICS INCORPORATED Independent Dir/Board Member - -
Chairman - -
Director/Board Member 01/07/2016 -
Corporate Officer/Principal 29/05/2009 -
American Society for Pharmacology & Experimental Therapeutic Corporate Officer/Principal 29/05/2009 -
Corporate Officer/Principal - -

Career history of Paul Friedman

Former positions of Paul Friedman

CompaniesPositionStartEnd
ALEXION PHARMACEUTICALS, INC. Director/Board Member 14/09/2017 14/07/2021
Independent Dir/Board Member 14/09/2017 14/07/2021
INCYTE CORPORATION Director/Board Member 01/11/2001 26/05/2021
Chief Executive Officer 01/11/2001 13/11/2014
Independent Dir/Board Member 13/11/2014 26/05/2021
President 01/05/2004 13/11/2014
VERASTEM, INC. Director/Board Member 12/05/2014 27/04/2017
Independent Dir/Board Member 14/04/2015 27/04/2017
Director/Board Member 30/06/2016 02/01/2017
Chairman 29/10/2014 30/06/2016
Independent Dir/Board Member 01/01/2014 29/10/2014
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -

Training of Paul Friedman

Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Statistics

International

United States 22

Operational

Director/Board Member 13
Independent Dir/Board Member 9
Corporate Officer/Principal 5

Sectoral

Health Technology 17
Consumer Services 3
Commercial Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies4
INCYTE CORPORATION

Health Technology

VERASTEM, INC.

Health Technology

PRELUDE THERAPEUTICS INCORPORATED

Health Technology

MADRIGAL PHARMACEUTICALS, INC.

Health Technology

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

American Society for Pharmacology & Experimental Therapeutic

DuPont Pharmaceuticals Research Laboratories

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW